Valuation: CaliPharms, Inc.

Market Cap 401K 344K 322K 294K 553K 38.4M 560K 3.8M 1.48M 19.29M 1.51M 1.47M 63.8M P/E 2012 *
-
P/E 2013 -0.51x
Enterprise Value 1.07M 915K 856K 784K 1.47M 102M 1.49M 10.11M 3.94M 51.33M 4.01M 3.92M 170M EV / Sales 2012 *
-
EV / Sales 2013 -
Free-Float
100%
Yield 2012 *
-
Yield 2013 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 13.88K
-1.75%-1.40%-14.42%-5.80% 13.09B
-2.74%-2.90%-35.91%-58.08% 4.85B
-6.30%-6.88%-7.32%-6.01% 4.59B
-5.35%-3.01%+1.29%-26.92% 4.09B
-2.56%-2.27%-24.04%+2.40% 3.51B
-2.87%-0.49%-11.37%-6.48% 3.34B
-3.23%-2.35%-12.30%+13.41% 3.33B
-4.14%-2.45%-18.19%-14.63% 2.43B
-3.92%-3.50%-30.34%-13.28% 1.67B
Average -3.29%-2.70%-16.96%-12.82% 4.55B
Weighted average by Cap. -3.25%-2.35%-15.88%-12.75%

Financials

2012 2013
Net sales - -
Net income -917K -785K -735K -673K -1.26M -87.73M -1.28M -8.68M -3.39M -44.07M -3.44M -3.37M -146M -216K -185K -174K -159K -298K -20.71M -302K -2.05M -799K -10.4M -813K -795K -34.41M
Net Debt 617K 528K 494K 452K 849K 59M 860K 5.84M 2.28M 29.64M 2.32M 2.27M 98.04M 667K 571K 534K 489K 918K 63.79M 930K 6.31M 2.46M 32.04M 2.5M 2.45M 106M
Logo CaliPharms, Inc.
CaliPharms Inc is a developmental stage acquisition company. The Company is focused on acquiring, merging, and joint venturing with legally permitted fully operational marijuana-cannabis businesses. The Company is seeking acquisitions in medical marijuana-cannabis cultivation. The Company focuses on the medical-grade marijuana-cannabis within the State of California. The Company is also expanding into other sectors that support the legalized marijuana industry.
Employees
-